Royal Sense Ltd Launches Stergic Chikungunya IgG/IgM Rapid Test

Royal Sense Ltd, a leading provider of innovative diagnostic solutions, has announced the launch of its new product, the Stergic Chikungunya IgG/IgM Rapid Test. The test is designed to detect Chikungunya virus antibodies in blood, providing quick results for diagnosing recent or current infections. The Chikungunya rapid test is a valuable tool in areas where Chikungunya is prevalent, allowing for timely medical intervention. It is important to follow up with confirmatory testing and clinical evaluation for accurate diagnosis and treatment. The test will be available for sale from August 21, 2024.